Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

ClinicalTrials.gov ID: NCT00274638

Public ClinicalTrials.gov record NCT00274638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomised, Open-Label, Blinded-Endpoint, Parallel Group 6-week Treatment Study Comparing Telmisartan Combined With Hydrochlorothiazide (40 mg/12.5 mg or 80 mg/12.5 mg) Tablets With Losartan Combined With Hydrochlorothiazide (50 mg/12.5 mg) Tablets Using Ambulatory Blood Pressure Monitoring in Patients With Mild-to-Moderate Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate that Telmisartan combined with Hydrochlorothiazide (MICARDIS® HCT) is superior to Losartan with Hydrochlorothiazide (Hyzaar®) in lowering blood pressure in mild-moderate hypertensives.

Study identification

NCT ID
NCT00274638
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
805 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2002 (Type not available)
Primary completion
Jul 2003 (Actual)
Completion
Not listed
Last update posted
Dec 9, 2013

Started 2002

United States locations

U.S. sites
69
U.S. states
26
U.S. cities
60
Facility City State ZIP Site status
Boehringer Ingelheim Investigational Site Huntsville Alabama — —
Research Solutions, LLC Little Rock Arkansas — —
Boehringer Ingelheim Investigational Site Carmichael California — —
Boehringer Ingelheim Investigational Site Concord California — —
Sierra Medical Research Fresno California — —
Attn: Ginger Paselk Long Beach California — —
Boehringer Ingelheim Investigational Site Orange California — —
DeBruin Medical Center Orangevale California — —
Clinical Trials Research Roseville California — —
Dr. R. David Ferrera Sacramento California — —
Westlake Medical Research Westlake Village California — —
Rocky Mountain Pulmonary & Critical Care Medicine, Inc. Wheat Ridge Colorado — —
Clinical Research Consultants, Inc. Trumbull Connecticut — —
Glasgow Family Pract6ice Newark Delaware — —
Boehringer Ingelheim Investigational Site Coral Gables Florida — —
Miami Research Associates Coral Gables Florida — —
Patron, Andres, D.O. Hollywood Florida — —
Christopher Chappel, MD Kissimmee Florida — —
Boehringer Ingelheim Investigational Site Melbourne Florida — —
Orlando Clinical Research Center Orlando Florida — —
Attention: Larry I. Gilderman, D.O. Pembroke Pines Florida — —
nTouch Research St. Petersburg Florida — —
Tampa Medical Research Associates Tampa Florida — —
Southern Clinical Research and Management, Inc. Augusta Georgia — —
Boehringer Ingelheim Investigational Site Conyers Georgia — —
Treasure Valley Cardiology Boise Idaho — —
Cedar-Crosse Research Center Chicago Illinois — —
Herron Medical Center, Ltd. Chicago Illinois — —
Protococare Trials, Inc. Elk Grove Village Illinois — —
N Touch Research Peoria Illinois — —
Midwest Institute for Clinical Research Inc. Indianapolis Indiana — —
Radiant Research Overland Kansas — —
Ong Medical Center Oxon Hill Maryland — —
Radiant Research Edina Minnesota — —
Cardiology Research Saint Paul Minnesota — —
Attention: Mel E. Lucas, DO Florissant Missouri — —
New Mexico Clinical Reaearch & Osteoporosis Center, Inc. Albuquerque New Mexico — —
Syracuse Preventative Cardiology Syracuse New York — —
Great Lakes Medical Research Westfield New York — —
Cardiology and Internal Medicine- Williamsville NY Williamsville New York — —
Comprehensive Clinical Research Bina North Carolina — —
Bennett Cardiac Center Charlotte North Carolina — —
Charlotte Clinical Research Charlotte North Carolina — —
Boehringer Ingelheim Investigational Site Raleigh North Carolina — —
nTouch Research Corporation Raleigh North Carolina — —
Piedmont Research Associates Winston-Salem North Carolina — —
Wake Forest University School of Medicine Winston-Salem North Carolina — —
Boehringer Ingelheim Investigational Site Cincinnati Ohio — —
Radiant Reseach Cincinnati Ohio — —
Radiant Research Columbus Ohio — —
Boehringer Ingelheim Investigational Site Oklahoma City Oklahoma — —
nTouch Oklahoma City Oklahoma — —
Hillcrest Medical Center Tulsa Oklahoma — —
Bock Clinical Research Collegeville Pennsylvania — —
Bock Clinical Research Downingtown Pennsylvania — —
Bock Clinical Research Harleysville Pennsylvania — —
The Western Pennsylvania Hospital Pittsburgh Pennsylvania — —
Omega Research Warwick Rhode Island — —
University of Tennessee Medical Center Knoxville Tennessee — —
Veterans Affairs Medical Center Memphis Tennessee — —
Clinical Research Associates, Inc. Nashville Tennessee — —
Boehringer Ingelheim Investigational Site Dallas Texas — —
nTouch Research Houston Texas — —
Hampton Roads Medical Specialists Hampton Virginia — —
885 Kempsville Road, Suite 221 Norfolk Virginia — —
York Clinical Research Norfolk Virginia — —
Boehringer Ingelheim Investigational Site Richmond Virginia — —
Gemini Scientific Madison Wisconsin — —
University of Wisconsin Medical School Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00274638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2013 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00274638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →